Tivic health completes optimization study for its non-invasive vagus nerve stimulation device

Fremont, calif.--(business wire)--tivic health® systems, inc. (nasdaq: tivc), a diversified immunotherapeutics company developing treatments that stimulate immune pathways to treat disease, today announced it has completed all study visits in the optimization study for its patent pending, non-invasive cervical vagus nerve stimulation (ncvns) device. initial findings reinforce the importance of personalization for therapeutic efficacy. tivic expects to release the study results later this year.
TIVC Ratings Summary
TIVC Quant Ranking